dacomitinib
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
3 FDA-registered drug labelers
MSN Laboratories Private Limited
Pfizer Laboratories Div Pfizer Inc
U.S. Pharmaceuticals
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Vizimpro
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS1110813-31-4
PubChem CID11511120
DTXSIDDTXSID50149493
FormulaC24H25ClFN5O2
Mol. Weight469.9 g/mol
SMILESCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4
Data Sources
115111202026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/dacomitinib/cids/JSON
Archive: data/sources/pubchem_name/dacomitinib.json
CAS 1110813-31-42026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json